Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-034764
Filing Date
2019-07-15
Accepted
2019-07-15 20:38:25
Documents
1
Period of Report
2019-07-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv525230_4.html 4  
1 OWNERSHIP DOCUMENT tv525230_4.xml 4 8842
  Complete submission text file 0001144204-19-034764.txt   10263
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EYEGATE PHARMACEUTICALS, INC. 271 WAVERLY OAKS ROAD, SUITE 108 WALTHAM MA 02452
Business Address
Wirostko Barbara (Reporting) CIK: 0001669087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 19956085